44 related articles for article (PubMed ID: 21934357)
1. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
[TBL] [Abstract][Full Text] [Related]
2. Global epigenetic regulation of microRNAs in multiple myeloma.
Zhang W; Wang YE; Zhang Y; Leleu X; Reagan M; Zhang Y; Mishima Y; Glavey S; Manier S; Sacco A; Jiang B; Roccaro AM; Ghobrial IM
PLoS One; 2014; 9(10):e110973. PubMed ID: 25330074
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation at the suppressor of cytokine signaling 3 (SOCS3) gene influences height in childhood.
Issarapu P; Arumalla M; Elliott HR; Nongmaithem SS; Sankareswaran A; Betts M; Sajjadi S; Kessler NJ; Bayyana S; Mansuri SR; Derakhshan M; Krishnaveni GV; Shrestha S; Kumaran K; Di Gravio C; Sahariah SA; Sanderson E; Relton CL; Ward KA; Moore SE; Prentice AM; Lillycrop KA; Fall CHD; Silver MJ; Chandak GR;
Nat Commun; 2023 Aug; 14(1):5200. PubMed ID: 37626025
[TBL] [Abstract][Full Text] [Related]
4. DNMTs-mediated SOCS3 methylation promotes the occurrence and development of AML.
Zhang X; Zhang K; Zhang J; Chang W; Zhao Y; Suo X
Eur J Haematol; 2024 Mar; 112(3):439-449. PubMed ID: 37950514
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-wide association analysis revealed that SOCS3 methylation influences the effect of cumulative stress on obesity.
Xu K; Zhang X; Wang Z; Hu Y; Sinha R
Biol Psychol; 2018 Jan; 131():63-71. PubMed ID: 27826092
[TBL] [Abstract][Full Text] [Related]
6. miR-29b: a new demethylator in multiple myeloma.
Benetatos L
Cell Cycle; 2013 Dec; 12(24):3718-9. PubMed ID: 24189534
[No Abstract] [Full Text] [Related]
7. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025
[TBL] [Abstract][Full Text] [Related]
8. SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer.
Sobah ML; Liongue C; Ward AC
Front Med (Lausanne); 2021; 8():727987. PubMed ID: 34604264
[TBL] [Abstract][Full Text] [Related]
9. Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications.
Schütt J; Nägler T; Schenk T; Brioli A
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439223
[TBL] [Abstract][Full Text] [Related]
10. A Network Analysis of Multiple Myeloma Related Gene Signatures.
Liu Y; Yu H; Yoo S; Lee E; Laganà A; Parekh S; Schadt EE; Wang L; Zhu J
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569720
[TBL] [Abstract][Full Text] [Related]
11. Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.
Wei L; Huang Y; Zhao R; Zhang J; Liu Q; Liang W; Ding X; Gao B; Li B; Sun C; He J; Yu X; Liu Z; Sun A; Qin Y
Clin Exp Med; 2018 Feb; 18(1):79-87. PubMed ID: 28951980
[TBL] [Abstract][Full Text] [Related]
12. SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.
Madonna S; Scarponi C; Morelli M; Sestito R; Scognamiglio PL; Marasco D; Albanesi C
Oncotarget; 2017 Apr; 8(15):24652-24667. PubMed ID: 28445952
[TBL] [Abstract][Full Text] [Related]
13. Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients.
Jiang BG; Wang N; Huang J; Yang Y; Sun LL; Pan ZY; Zhou WP
Oncotarget; 2017 Apr; 8(17):28621-28627. PubMed ID: 28404963
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanin CD37 protects against the development of B cell lymphoma.
de Winde CM; Veenbergen S; Young KH; Xu-Monette ZY; Wang XX; Xia Y; Jabbar KJ; van den Brand M; van der Schaaf A; Elfrink S; van Houdt IS; Gijbels MJ; van de Loo FA; Bennink MB; Hebeda KM; Groenen PJ; van Krieken JH; Figdor CG; van Spriel AB
J Clin Invest; 2016 Feb; 126(2):653-66. PubMed ID: 26784544
[TBL] [Abstract][Full Text] [Related]
15. Methylation and microRNA-mediated epigenetic regulation of SOCS3.
Boosani CS; Agrawal DK
Mol Biol Rep; 2015 Apr; 42(4):853-72. PubMed ID: 25682267
[TBL] [Abstract][Full Text] [Related]
16. SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer.
Wang J; Zhou H; Han Y; Liu X; Wang M; Wang X; Yin G; Li X; Xiang M
J Mol Med (Berl); 2014 Dec; 92(12):1257-69. PubMed ID: 24996521
[TBL] [Abstract][Full Text] [Related]
17. The role of suppressors of cytokine signalling in human neoplasms.
Sasi W; Sharma AK; Mokbel K
Mol Biol Int; 2014; 2014():630797. PubMed ID: 24757565
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of IFNG in CD4(+) T cells in lung cancer through hypermethylation: a possible mechanism of tumor-induced immunosuppression.
Wang F; Xu J; Zhu Q; Qin X; Cao Y; Lou J; Xu Y; Ke X; Li Q; Xie E; Zhang L; Sun R; Chen L; Fang B; Pan S
PLoS One; 2013; 8(11):e79064. PubMed ID: 24244422
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modulating agents as a new therapeutic approach in multiple myeloma.
Maes K; Menu E; Van Valckenborgh E; Van Riet I; Vanderkerken K; De Bruyne E
Cancers (Basel); 2013 Apr; 5(2):430-61. PubMed ID: 24216985
[TBL] [Abstract][Full Text] [Related]
20. Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis.
Heuck CJ; Mehta J; Bhagat T; Gundabolu K; Yu Y; Khan S; Chrysofakis G; Schinke C; Tariman J; Vickrey E; Pulliam N; Nischal S; Zhou L; Bhattacharyya S; Meagher R; Hu C; Maqbool S; Suzuki M; Parekh S; Reu F; Steidl U; Greally J; Verma A; Singhal SB
J Immunol; 2013 Mar; 190(6):2966-75. PubMed ID: 23408834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
